Breakthrough Alzheimer's Drug Targets Key 'Hotspots' to
WEB20 hours ago · Brains affected by Alzheimer's disease are characterized by damaging clumps and tangles that interfere with neurons – but a new study describes a drug that could potentially suppress half the problem. The drug is RI-AG03, and it's a peptide inhibitor (a blocker of proteins). In tests on fruit flies and human cells, it has shown a positive ...
New Alzheimer's Treatment Shows Promise by Dual-Targeting Tau …
WEB4 days ago · Before joining Technology Networks she researched maternal health and the microbiome. A new drug, RI-AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to Alzheimer's disease. Early tests demonstrated the drug's effectiveness in reducing tau aggregation.
Promising Alzheimer's drug candidate prevents buildup of tau …
WEB4 days ago · The drug, a peptide inhibitor called RI-AG03, was effective at preventing the buildup of tau proteins in both lab and fruit fly studies. The research, published in Alzheimer's & Dementia, was...
Alzheimer’s breakthrough after drug treatment success
WEB5 days ago · News Science Alzheimer’s breakthrough after drug treatment success Study found that the medication, called RI-AG03, was effective at preventing the buildup of Tau proteins
Alzheimer’s Game Changer: Dual-Action Drug Attacks
WEB4 days ago · A new peptide inhibitor, RI-AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models. This innovative approach could lead to treatments that slow disease progression with minimal side effects. An international team of scientists led
A novel peptide-based tau aggregation inhibitor as a potential ...
WEB5 days ago · RI-AG03 also rescues a biosensor cell line that stably expresses Tau repeat domains with the P301S mutation fused to Cer/Clo and rescues aggregation-dependent phenotypes in vivo, suppressing neurodegeneration and extending lifespan. Collectively our data describe several properties and attributes of RI-AG03 that make it …
‘One-of-a-kind’ new Alzheimer’s drug shows promise: ‘An ... - Yahoo
WEB4 days ago · Now, an international team led by Lancaster University in the UK says it has developed a drug called RI-AG03 that targets and blocks the two “hot spots” where tau clumping tends to occur.
Promising ‘first’ in Alzheimer’s drug development
WEB5 days ago · The drug, a peptide inhibitor called RI-AG03, was effective at preventing the build-up of Tau proteins – a key driver of neurodegeneration – in both lab and fruit fly studies.
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
WEB4 days ago · This peptide inhibitor, RI-AG03, effectively prevents Tau buildup in lab studies and fruit flies, offering hope for new Alzheimer’s treatments. Unlike current drugs, RI-AG03 uniquely blocks both Tau “hotspots,” potentially leading to safer, more targeted therapies. Researchers plan to test the drug in rodents before advancing to clinical ...
Promising ‘first’ in Alzheimer’s drug development
WEB4 days ago · Testing RI-AG03. To test its effectiveness in cells within a living organism, researchers at the University of Southampton then gave the drug to fruit flies that had pathogenic Tau. ... Back to News. Our research represents an important step toward creating treatments that can prevent the progression of diseases like …
- Some results have been removed